Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Tavapadon, an Orally Administered, Once-daily, Selective D1/D5 Partial Dopamine Agonist, Adjunctive to Levodopa for Treatment of Parkinson’s Disease with Motor Fluctuations

              Author:Fernandez, Hubert   Isaacson, Stuart   Hauser, Robert   Agarwal, Pinky   Ondo, William   Park, Ariane   Elmer, Lawrence   Kremens, Daniel   Leoni, Matthew   Duvvuri, Sridhar   Combs, Cari   Koenig, Erica   Chang, Ih   Pastino, Gina   Tringali, Stacey   Golonski, Nicole   Sanchez, Raymon   

              Session Name:S37: Movement Disorders: Clinical Trials  

              Topic:Movement Disorders  

              Program Number:S37.003  

              Author Institution:Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH  Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton, FL  USF Parkinson's Disease and Movement Disorders Center, Tampa, FL  Evergreen Health, Kirkland, WA  Houston Methodist Neurological Institute, Houston, TX  The Ohio State University Wexner Medical Center, Columbus, OH  Division of Movement Disorders, Department of Neurology, University of Toledo, Toledo, OH  Thomas Jefferson University, Philadelphia, PA  Cerevel Therapeutics, Cambridge, MA  

              Transcutaneous Afferent Patterned Stimulation Provides Sustained Benefit in Essential Tremor (PROSPECT Study)

              Author:Peckham, Elizabeth   Tse, Winona   Petrossian, Melita   Lew, Mark   Agarwal, Pinky   Dhall, Rohit   Shill, Holly   Tate, Jessica   Ondo, William   Hallett, Mark   Lu, Chiahao   Rosenbluth, Kathryn   Pahwa, Rajesh   

              Session Name:P1: Movement Disorders: Essential Tremor and Other Tremor Disorders  

              Topic:Movement Disorders  

              Program Number:P1.002  

              Author Institution:Central Texas Neurology Consultants, Round Rock, TX  Mount sinai medical center, New York, NY  Pacific Movement Disorders Center, Santa Monica, CA  USC School of Medicine, Los Angeles, CA  Evergreen Health, Kirkland, WA  University of Arkansas for Medical Sciences, Little Rock, AR  Barrow Neurology Clinics, Phoenix, AZ  Atrium Health Wake Forest Baptist, Winston Salem, NC  Methodist Neurological Institute, Houston, TX  National Institutes of Health, Bethesda, MD  Cala Health, San Mateo, CA  Cala Health, San Francisco, CA  University of Kansas Medical Center, Kansas City, KS  

              Conversion to CREXONT® in the RISE-PD Phase 3 Trial Improved Aspects of Sleep as Measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2)

              Author:Ondo, William   Hauser, Robert   Grieb, Zachary   Banisadr, Ghazal   Fisher, Stanley   

              Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

              Topic:Movement Disorders  

              Program Number:P11.004  

              Author Institution:Methodist Neurological Institute, Houston, TX  Movement Disorders Center, Tampa, FL  Amneal Pharmaceuticals, Bridgewater, NJ  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ